EUCTR2012-000215-89-GB进行中（未招募）1 期
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial function An international, multicentre, randomised, double-blind, placebo-controlled study over 12 weeks.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •- Men or postmenopausal women of any ethnic origin aged between 21 and 74 years
- •- In sinus rhythm with resting HR at least 75 bpm
- •- At increased risk of subsequent cardiovascular disease (documented by the presence of at least two cardiovascular risk factors such as diabetes, hypertension, smoking, hypercholesterolemia) and impaired FMD (<5.0%)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 270
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 70
排除标准
- •- Previous diagnosis of coronary heart disease
- •- Previous diagnosis of heart failure or current clinical signs or symptoms in keeping with a diagnosis of heart failure
- •- History of cerebrovascular or peripheral arterial disease
- •- Uncontrolled hypertension
- •- Chronic infectious or inflammatory disease
- •- Chronic Obstructive Pulmonary Disease (COPD) treated with inhaled bronchodilators
- •- Malignancy
- •- Current therapy with nicorandil, nitrate, insulin
- •- Contra-indication to ivabradine
研究者
相似试验
已完成
2 期
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial function;An international, multicentre, randomised, double-blind, placebo-controlled study over 12 weeks.impaired endothelial function10003216NL-OMON40596Servier R&D Benelux200
进行中（未招募）
不适用
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial functioCardiovascular diseaseEUCTR2012-000215-89-NLInstitut de Recherches Internationales Servier340
进行中（未招募）
不适用
Effects of ivabradine on vascular function in individuals at increased risk of developing cardiovascular disease and with impaired endothelial functioCardiovascular diseaseMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849EUCTR2012-000215-89-ITInstitut de Recherches Internationales Servier340
进行中（未招募）
1 期
Efectos de ivabradina en pacientes con arteriopatía coronaria estable sin insuficiencia cardíaca clínica. Estudio multicéntrico, internacional, aleatorizado, doble ciego, controlado con placeboStudy assessInG the morbi-mortality beNefits of the If inhibitor ivabradine in patients with coronary arterY disease (SIGNIFY)Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre study.Study assessInG the morbi-mortality beNefits of the If inhibitor ivabradine in patients with coronary arterY disease (SIGNIFY) - SIGNIFYArteriopatia Coronaria EstableStable coronary artery diseaseMedDRA version: 12.0Level: LLTClassification code 10011078Term: <Manually entered code. Term in E.1.1>EUCTR2009-011360-10-ESInstitut de Recherches Internationales Servier19,102
进行中（未招募）
不适用
Effects of ivabradine on cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study. - BEAUTIFCoronary artery diseaseMedDRA version: 7.0Level: PTClassification code 10011078EUCTR2004-001959-11-FIInstitut de Recherches Internationales9,650